Clinical Experience with Adalimumab in the Treatment of Ocular Behçet Disease

By Bawazeer Ahmed   Raffa Lina H.   given-names given-names Nizamuddin  

Ocular Immunology and Inflammation, Vol. 18, Iss. 3, 2010-06 ,pp. : 226-232

Informa Healthcare

Access to resources Recommend Favorite

Clinical course of ocular Behçet's disease in siblings

By Onal Sumru   Tugal-Tutkun Ilknur   Urgancioglu Meri   Gul Ahmet  

Ocular Immunology and Inflammation, Vol. 9, Iss. 2, 2001-06 ,pp. : 111-124

Informa Healthcare

Access to resources Recommend Favorite

Behçet's disease in Western Switzerland: Epidemiology and analysis of ocular involvement

By Ambresin A.   Tao Tran V.   Spertini François   Herbort Carl P.  

Ocular Immunology and Inflammation, Vol. 10, Iss. 1, 2002-03 ,pp. : 53-63

Informa Healthcare

Access to resources Recommend Favorite

Demographic, Clinical, and Ocular Features in Patients with Late-onset Behçet Disease

By Hazirolan Dicle   Sungur Gulten   Duman Sunay  

Ocular Immunology and Inflammation, Vol. 20, Iss. 2, 2012-04 ,pp. : 119-124

Informa Healthcare

Access to resources Recommend Favorite

The demonstration of serum interleukin 6–8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet's disease with ocular involvement

By Bardak Yavuz   Aridogan Buket Cicioglu  

Ocular Immunology and Inflammation, Vol. 12, Iss. 1, 2004-03 ,pp. : 53-58

Informa Healthcare

Access to resources Recommend Favorite